TrovaGene Inc ’s ( TROV ) share price has entered into oversold territory with an RSI value of 28.9. The Zacks Consensus Estimate for TrovaGene for the full year period has improved 13 cents over the past two months to -91 cents per share. Currently, TrovaGene has a Zacks Rank #1 (Strong Buy), suggesting that now might be a good time to get in on ( TROV ) after its recent drop.
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment